HomeProductsBioactive CompoundsTransporters & Ion ChannelsGABA ReceptorArbaclofen Placarbil
Chemical structure of CAS 847353-30-4

Arbaclofen Placarbil

CAS No.847353-30-4
MDL No.N/A
MFC19H26ClNO6
MW399.90
InChI KeyJXTAALBWJQJLGN-KSSFIOAISA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.847353-30-4
Product NameArbaclofen Placarbil

Biological Targets

GABBR1·GABBR2

Associated Conditions

Back pain·multiple sclerosis·Spasticity·alcohol dependence·gastroesophageal reflux disease
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Fragile X syndrome and targeted treatment trials.

Results and problems in cell differentiation • Vol. 54 • 2012
PMID: 22009360PMC: PMC4114775DOI: 10.1007/978-3-642-21649-7_17

Efficacy and safety study of arbaclofen placarbil in patients with spasticity due to spinal cord injury.

Spinal cord • Vol. 49, Issue 9 • 2011
PMID: 21577221DOI: 10.1038/sc.2011.43

Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled study.

The American journal of gastroenterology • Vol. 106, Issue 8 • 2011
PMID: 21519360DOI: 10.1038/ajg.2011.121

What is nonacid reflux disease?

Canadian journal of gastroenterology = Journal canadien de gastroenterologie • Vol. 25, Issue 1 • 2011
PMID: 21258666PMC: PMC3027332DOI: 10.1155/2011/626752

Documentation